Fund Holdings — Exome Asset Management LLC

Total Portfolio Value:
$121.28M
Total Bought:
$38.91M
Total Sold:
$36.53M
Net Transaction:
+$2.38M
Notable People:
Alex R Forschner
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Ishares TrPUT0200,000+200,000$0$7.35M6.06%+$7.35M
BridgeBio Pharma, Inc.(BBIO)165,496155,533-9,963$5.72M$6.72M5.54%+$994.7K
Guardant Health, Inc.(GH)127,18298,182-29,000$5.42M$5.11M4.21%-$308.6K
Geron Corporation(GERN)3,215,4573,414,377+198,920$5.11M$4.81M3.97%-$298.3K
Ionis Pharmaceuticals, Inc.(IONS)135,616121,116-14,500$4.09M$4.79M3.95%+$693.8K
Tenet Healthcare Corporation(THC)027,000+27,000$0$4.75M3.92%+$4.75M
Cogent Biosciences, Inc.(COGT)621,678533,647-88,031$3.72M$3.83M3.16%+$107.7K
Cytokinetics, Incorporated(CYTK)103,483115,817+12,334$4.16M$3.83M3.16%-$332.4K
Replimune Group, Inc.(REPL)294,846397,846+103,000$2.87M$3.70M3.05%+$821.2K
Eli Lilly and Company(LLY)4,6734,6730$3.86M$3.64M3.00%-$216.7K
Soleno Therapeutics Inc43,44141,641-1,800$3.10M$3.49M2.88%+$384.8K
Intuitive Surgical, Inc.(ISRG)6,3586,3580$3.15M$3.46M2.85%+$306.1K
Disc Medicine, Inc.(IRON)61,65661,356-300$3.06M$3.25M2.68%+$188.8K
Natera, Inc.(NTRA)18,65018,6500$2.64M$3.15M2.60%+$513.4K
Fulcrum Therapeutics, Inc.(FULC)689,137444,949-244,188$1.98M$3.06M2.52%+$1.08M
Scholar Rock Holding Corporation(SRRK)84,33984,3390$2.71M$2.99M2.46%+$275.8K
Syndax Pharmaceuticals, Inc.(SNDX)337,198308,298-28,900$4.14M$2.89M2.38%-$1.26M
Verastem, Inc.(VSTM)0599,900+599,900$0$2.49M2.05%+$2.49M
Praxis Precision Medicines, Inc.(PRAX)059,002+59,002$0$2.48M2.05%+$2.48M
Penumbra, Inc.(PEN)9,0009,0000$2.41M$2.31M1.90%-$97.0K
89bio Inc353,882233,426-120,456$2.57M$2.29M1.89%-$280.5K
Travere Therapeutics, Inc.(TVTX)118,017153,278+35,261$2.11M$2.27M1.87%+$153.6K
Centessa Pharmaceuticals PlcADS142,744166,944+24,200$2.05M$2.19M1.81%+$141.0K
Nektar TherapeuticsCALL(NKTR)075,000+75,000$0$1.94M1.60%+$1.94M
Waystar Holding Corp.(WAY)046,900+46,900$0$1.92M1.58%+$1.92M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)289,690277,317-12,373$1.54M$1.91M1.58%+$375.2K
10x Genomics, Inc.CL A(TXG)0163,658+163,658$0$1.90M1.56%+$1.90M
Dyne Therapeutics, Inc.(DYN)258,391195,933-62,458$2.70M$1.87M1.54%-$837.5K
REGENXBIO Inc.(RGNX)405,281226,060-179,221$2.90M$1.86M1.53%-$1.04M
Universal Health Services, Inc.CL B(UHS)010,100+10,100$0$1.83M1.51%+$1.83M
Vera Therapeutics, Inc.CL A(VERA)076,700+76,700$0$1.81M1.49%+$1.81M
Crinetics Pharmaceuticals In51,29562,700+11,405$1.72M$1.80M1.49%+$82.8K
Apellis Pharmaceuticals Inc
COM
098,600+98,600$0$1.71M1.41%+$1.71M
Edgewise Therapeutics, Inc.(EWTX)71,438124,470+53,032$1.57M$1.63M1.35%+$60.2K
Travere Therapeutics, Inc.CALL(TVTX)0110,000+110,000$0$1.63M1.34%+$1.63M
BioCryst Pharmaceuticals, Inc.(BCRX)60,600172,883+112,283$454.5K$1.55M1.28%+$1.09M
Karyopharm Therapeutics IncNOTE 3 000 10 12,000,0002,000,0000$1.52M$1.52M1.26%+$1.2K
Celldex Therapeutics, Inc.(CLDX)073,000+73,000$0$1.49M1.22%+$1.49M
Sarepta Therapeutics, Inc.NOTE 1 250 9 1(SRPT)02,000,000+2,000,000$0$1.45M1.19%+$1.45M
Gossamer Bio, Inc.(GOSS)1,097,9991,097,9990$1.21M$1.35M1.11%+$142.7K
Structure Therapeutics IncADS102,94453,744-49,200$1.78M$1.11M0.92%-$667.3K
Legend Biotech CorporationADS(LEGN)029,100+29,100$0$1.03M0.85%+$1.03M
MBX Biosciences, Inc.(MBX)133,11363,076-70,037$982.4K$719.7K0.59%-$262.7K
Alvotech(ALVO)90,10078,372-11,728$871.3K$714.8K0.59%-$156.5K
Newamsterdam Pharma Company
ORDINARY SHARES
036,574+36,574$0$662.4K0.55%+$662.4K
COMPASS Pathways plcADS(CMPS)0213,544+213,544$0$597.9K0.49%+$597.9K
Establishment Labs Holdings Inc.(ESTA)13,10013,1000$534.5K$559.5K0.46%+$25.0K
Yarrow Bioscience Inc(YARW)462,801208,970-253,831$731.2K$344.8K0.28%-$386.4K
Instil Bio, Inc.(TIL)016,200+16,200$0$337.4K0.28%+$337.4K
Anaptysbio Inc116,62315,000-101,623$2.17M$333.0K0.27%-$1.84M
Eledon Pharmaceuticals, Inc.(ELDN)114,145114,1450$387.0K$309.3K0.26%-$77.6K
Liquidia Corporation(LQDA)020,500+20,500$0$255.4K0.21%+$255.4K
Arbutus Biopharma Corporation(ABUS)075,484+75,484$0$233.2K0.19%+$233.2K
Elevation Oncology Inc0110,353+110,353$0$40.5K0.03%+$40.5K
Mereo BioPharma Group plcPUT(MREO)014,600+14,600$0$39.6K0.03%+$39.6K
Akebia Therapeutics, Inc.(AKBA)189,0870-189,087$363.0K$0—-$363.0K
Akero Therapeutics Inc76,3790-76,379$3.09M$0—-$3.09M
Aprea Therapeutics, Inc.(APRE)28,9720-28,972$59.1K$0—-$59.1K
Arvinas, Inc.(ARVN)195,2950-195,295$1.37M$0—-$1.37M
AstraZeneca PLCADR(AZN)32,5340-32,534$4.73M$0—-$4.73M
BeOne Medicines AGADS(ONC)6,5000-6,500$1.77M$0—-$1.77M
Biohaven Ltd.(BHVN)39,9000-39,900$959.2K$0—-$959.2K
Dr. Reddy's Laboratories LimitedADR(RDY)117,5000-117,500$1.55M$0—-$1.55M
GE HealthCare Technologies Inc.(GEHC)25,4000-25,400$2.05M$0—-$2.05M
Immunome, Inc.(IMNM)263,8410-263,841$1.78M$0—-$1.78M
Nektar Therapeutics(NKTR)2,232,4530-2,232,453$1.52M$0—-$1.52M
Nuvation Bio Inc.CL A(NUVB)96,3110-96,311$169.5K$0—-$169.5K
Savara Inc.(SVRA)836,3970-836,397$2.32M$0—-$2.32M
Trevi Therapeutics, Inc.(TRVI)163,7380-163,738$1.03M$0—-$1.03M
Viridian Therapeutics, Inc.(VRDN)217,2940-217,294$2.93M$0—-$2.93M
Page 1 of 1
Exome Asset Management LLC — 13F Holdings — Q2 2025 | TickerTrail